Officials at Solvias, a CRO headquartered in Kaiseraugst, Switzerland, say the company is expanding its global network of laboratory testing centers with a new biotech site in Research Triangle Park, NC. It is the company’s latest investment to expand its analytical testing services supporting life science organizations with the growing number of cell and gene therapies (CGTs) and biologics in use and under development, according to Solvias..

总部位于瑞士凯瑟劳格斯特的首席风险官索尔维亚（Solvias）的官员表示，该公司正在扩大其实验室测试中心的全球网络，并在北卡罗来纳州三角研究公园（Research Triangle Park）建立了一个新的生物技术基地。据索尔维亚（Solvias）称，这是该公司最新的一项投资，旨在扩大其分析测试服务，以支持生命科学组织，同时支持越来越多的细胞和基因疗法（CGT）以及正在使用和正在开发的生物制剂。。

The 50,000 ft2 facility, expected to be completed in 2025 and bring 170+ jobs to the Raleigh-Durham area, will serve as Solvias’ North American hub for large molecule analytical services and will offer cell-based potency assays, advanced NGS capabilities, and related testing services supporting multiple biologic modalities, noted Archie Cullen, CEO of the company..

该公司首席执行官阿尔奇·卡伦（ArchieCullen）指出，这座50000平方英尺的设施预计将于2025年完工，为罗利-达勒姆地区带来170多个就业岗位，将成为索维亚（Solvias）的北美大分子分析服务中心，并将提供基于细胞的效价测定、先进的NGS功能以及支持多种生物模式的相关测试服务。。

From the outset, the new testing center will support characterization and release testing of CGTs and other advanced therapies, including adeno-associated virus (AAV) gene therapies, mRNA therapies, and antibody drug conjugates. [Solvias]“Our new center strongly complements our biologics and CGT sites in Europe and expands our world-class testing capabilities in the U.S.

从一开始，新的测试中心将支持CGT和其他先进疗法的表征和释放测试，包括腺相关病毒（AAV）基因疗法，mRNA疗法和抗体-药物偶联物。[索维亚]“我们的新中心有力地补充了我们在欧洲的生物制剂和CGT站点，并扩大了我们在美国的世界级测试能力。

Our team is thrilled to bring our newest center of excellence to Research Triangle Park, a leading research and development center and burgeoning hub for the life science industry,” said Cullen..

我们的团队很高兴将我们最新的卓越中心带到三角研究园，三角研究园是一个领先的研发中心，也是生命科学行业的新兴中心，”卡伦说。。

In addition to the new RTP lab and Solvias’ headquarters in Kaiseraugst, Switzerland, the four other centers of excellence are located in Basel, Switzerland; Hombourg, France; Utrecht, The Netherlands; and Canton, MA, in the United States.

除了新的RTP实验室和位于瑞士凯瑟劳格斯特的索尔维亚总部外，其他四个卓越中心位于瑞士巴塞尔；法国霍姆堡；荷兰乌得勒支；和美国马萨诸塞州的广州。

NewsCell therapyGene therapy (Therapeutics)RNA-based therapeuticsSolvias

新细胞疗法基因疗法（Therapeutics）基于RNA的疗法